“…4,7 To develop specific cell-scaffolds for tissue regeneration, biologically active motifs for cell attachment can be chemically conjugated to create functional hydrogels through selfassembly. 3,[10][11][12][13] As bulky proteins have disadvantages in terms of immunogenicity and sudden loss of bioactivity, accumulating evidence supports the use of bioactivitymimicking peptides such as RGD, QK and QHREDGS, as surrogates for fibronectin, vessel endothelial growth factor (VEGF), and angiopoietin-1, respectively, to increase the bioactivity of engineered matrices. [14][15][16] The 12-peptide sequence GYGSSSRRAPQT, known as the C domain of insulin-like growth factor-1 (IGF-1C), has been identified as the active region of the IGF-1 protein, which can increase stem cell survival and substantially improve renal function in acute kidney injury (AKI) 17,18 .…”